Coforge: Kotak Inst Eqt On Coforge – Buy, Target Price cut to Rs 1620 from Rs 2250

 05 Mar 2026 09:06 AM

Coforge: Kotak Inst Eqt On Coforge – Buy, Target Price cut to Rs 1620 from Rs 2250

Coforge: Forms Strategic Partnership With VHC Health To Improve Provider Experience By Offering Digital And IT Services Such As Cloud, Cybersecurity, And AI Operations.

 26 Feb 2026 10:14 AM

Coforge: Forms Strategic Partnership With VHC Health To Improve Provider Experience By Offering Digital And IT Services Such As Cloud, Cybersecurity, And AI Operations.

Coforge: Co Signs $158 Million Or 1,400 Cr Rs Contract With UK Client For 5 Years.

 25 Feb 2026 11:16 AM

Coforge: Co Signs $158 Million Or 1,400 Cr Rs Contract With UK Client For 5 Years.

CLSA on Coforge TP reduced from Rs 2426 to Rs 2278/share (Outperform-High Conviction)

 24 Feb 2026 08:45 AM

CLSA on Coforge TP reduced from Rs 2426 to Rs 2278/share (Outperform-High Conviction)

CLSA on Coforge High Conviction O-P, TP Rs 2426

 19 Feb 2026 08:23 AM

CLSA on Coforge High Conviction O-P, TP Rs 2426

Coforge: Company Enhances CodeInsightAI With Agentic AI Features for Business Upgrades.

 11 Feb 2026 11:03 AM

Coforge: Company Enhances CodeInsightAI With Agentic AI Features for Business Upgrades.

Coforge: Gets Early Antitrust Approval From U.S. For Encora Deal; Waiting Period Ends Sooner Than Expected

 29 Jan 2026 09:51 PM

Coforge: Gets Early Antitrust Approval From U.S. For Encora Deal; Waiting Period Ends Sooner Than Expected

Coforge: Innovaccer And Company Team Up To Speed Up AI Changes In Healthcare

 27 Jan 2026 06:40 AM

Coforge: Innovaccer And Company Team Up To Speed Up AI Changes In Healthcare

Coforge: Reports Strong Quarter With Revenue Growth Of 5.1% QOQ, 28.5% YOY, And 37.3% YTD

 23 Jan 2026 05:56 PM

Coforge: Reports Strong Quarter With Revenue Growth Of 5.1% QOQ, 28.5% YOY, And 37.3% YTD

Coforge: Executive Advises Against Proceeding with QIP.

 23 Jan 2026 11:17 AM

Coforge: Executive Advises Against Proceeding with QIP.

COFORGE: Q3 CONS NET PROFIT 2.5B RUPEES VS 3.76B (QOQ)

 23 Jan 2026 06:56 AM

COFORGE: Q3 CONS NET PROFIT 2.5B RUPEES VS 3.76B (QOQ)

COFORGE: Q3 REVENUE 41.88B RUPEES VS 39.85B (QOQ)

 23 Jan 2026 06:56 AM

COFORGE: Q3 REVENUE 41.88B RUPEES VS 39.85B (QOQ)

COFORGE: Q3 EBIT 5.6B RUPEES VS 5.6B (QOQ) || Q3 EBIT MARGIN 13.36% VS 14.07% (QOQ)

 23 Jan 2026 06:56 AM

COFORGE: Q3 EBIT 5.6B RUPEES VS 5.6B (QOQ) || Q3 EBIT MARGIN 13.36% VS 14.07% (QOQ)

COFORGE: CO DECLARES THIRD INTERIM DIVIDEND OF RS 4 PER EQUITY SHARE

 23 Jan 2026 06:57 AM

COFORGE: CO DECLARES THIRD INTERIM DIVIDEND OF RS 4 PER EQUITY SHARE

COFORGE: Q3 PROFIT BEFORE EXCEPTIONAL ITEMS 5.3B VS 5.6B (QOQ) || CO HAS AN EXCEPTIONAL ITEM OF 1.5B

 23 Jan 2026 06:57 AM

COFORGE: Q3 PROFIT BEFORE EXCEPTIONAL ITEMS 5.3B VS 5.6B (QOQ) || CO HAS AN EXCEPTIONAL ITEM OF 1.5B

Coforge: CLSA on Coforge Outperform Target Price Rs 2,411

 05 Jan 2026 09:07 AM

Coforge: CLSA on Coforge Outperform Target Price Rs 2,411

Coforge: Citi on Coforge Maintain Sell with ticket price of Rs 1570 vs 1530

 02 Jan 2026 09:09 AM

Coforge: Citi on Coforge Maintain Sell with ticket price of Rs 1570 vs 1530

Coforge: EBIT Margin Grows By 60 Basis Points To 18.0% Due To $10 Million In Cost Synergies From Higher EBITDA Margin And A 5% Increase In Revenue In Higher-Margin Areas.

 29 Dec 2025 09:14 AM

Coforge: EBIT Margin Grows By 60 Basis Points To 18.0% Due To $10 Million In Cost Synergies From Higher EBITDA Margin And A 5% Increase In Revenue In Higher-Margin Areas.

Coforge: MS on Coforge OW, Price Target Rs 2030

 29 Dec 2025 09:04 AM

Coforge: MS on Coforge OW, Price Target Rs 2030

Coforge: CLSA on Coforge maintains 'Outperform' with Price Target of Rs 2275

 29 Dec 2025 09:04 AM

Coforge: CLSA on Coforge maintains 'Outperform' with Price Target of Rs 2275